A multicenter prospective cohort trial using of One Step Nuclei Acid Amplification Method in sentinel lymph node biopsy for early breast cancer patients
Not Applicable
- Conditions
- cT1-2N0M0 breast cancer patients
- Registration Number
- JPRN-UMIN000012623
- Lead Sponsor
- Sagara Hospital, Social Medical Corporation Hakuaikai
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 4500
Inclusion Criteria
Not provided
Exclusion Criteria
1)patients who had neoaduvant therapy 2)We did not obtain informed consent from all patients who participated in this study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Disease free survival
- Secondary Outcome Measures
Name Time Method Overall survival, local recurrence rate, postoperative complication, non-SLN metastasis rate in patient with ALND